90% of Pediatric Participants on CRENESSITY versus 21% on Placebo Achieved ≥1 Threshold for Androstenedione Reduction or Glucocorticoid Reduction Observed Rates of Select Reproductive Hormone...

Fed-civ, defense, and industry technology experts to gather for one-day event hosted by Agile Defense MCLEAN, Va., May 15, 2025 /PRNewswire/ -- Some of the nation's leading artificial intelligence...

Executives from The E.W. Scripps Company (NASDAQ: SSP) will discuss the company's business strategies at the Gabelli 17th Annual Media & Sports Symposium at The Harvard Club in New York City on...

The American Board of Quality Assurance & Utilization Review Physicians is pleased to announce the selection of Karen Clark, MD, MACP, FRCP, CHCQM-PHYADV, as the winner of the 2025 CHCQM Diplomate...

ISTURISA® (osilodrostat) is a cortisol synthesis inhibitor that blocks the enzyme 11beta-hydroxylase to help normalize hypercortisolemia in Cushing's syndrome, a rare endocrine condition that can...